CLINICAL_TRIALS
trial_result
· 2020-03-27
Clinical Trial Update: Characterization of Epilepsy Patients BEEP 2b [Phase 1]
Summary
Phase 1 trial update characterizing epilepsy patients in the BEEP 2b study; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Food and Drug Administration (FDA) | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2020-03-27